About this trial
The goal of this randomized controlled trial is to evaluate the effectiveness of video conferencing for the delivery of live-supervised, real-time cardiac rehabilitation (CR) exercise training to groups of adolescents with congenital heart disease (CHD) in their homes. Participants will be randomized to either the remote cardiac rehab (RCR) group or active control group. The RCR group will participate in live, group-based exercise training (3-5 participants per exercise session), in their homes 3 days per week for 45 minutes over 12-weeks. Exercise sessions will be led and supervised by a live health coach via telehealth video technology. The active control group will be provided informational handouts on health exercise for their cardiac diagnosis. The primary aim is to compare between group changes (0-12-weeks) in cardiorespiratory fitness (VO2peak). Secondary aims are to compare between group changes (0-12-weeks) in cardiac function (echocardiography), lean body mass, and physical frailty. Exploratory aims will compare between group changes (0-12-weeks) in physical function, quality of life, skeletal muscle function, and physical activity self-efficacy. Additionally, exploratory aims will explore the impact of demographic characteristics, program participation, program satisfaction, and daily physical activity on changes in cardiorespiratory fitness.
Eligibility criteria
Qualifiers
Age 12-19 years old
Male or Female
Primary Cardiology clearance for exercise participation
Internet access in their homes
Disqualifiers
Physically or developmentally unable to perform outcomes assessments or participate in moderate-to-vigorous intensity physical activity
Participating in > 15 MET-hours per week (mean weekly average over the past 12-months) of organized athletic/exercise activity (not including school physical education class).
Height less than 132cm
Pregnancy or planned surgery or procedure (excluding outpatient, non-cardiac procedures) within the 12-week study period.
Trial design
Treatments tested in this trial
- Remote Cardiac Rehabilitation
- Active Control
Treatment groups
Sponsors and collaborators
Children's Mercy Hospital Kansas City
Lead sponsor
University of Kansas
Collaborator
Children's Hospital of Philadelphia
Collaborator
University of North Carolina, Chapel Hill
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator